Page last updated: 2024-11-04

risedronic acid and Neoplasm Metastasis

risedronic acid has been researched along with Neoplasm Metastasis in 2 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research Excerpts

ExcerptRelevanceReference
"Here, in a new approach for bone metastasis prevention, we employed poly-l-lysine covalently grafted with beta-cyclodextrin as a polycationic vector (PLL-CD) for the antitumor bisphosphonate drug risedronate (RIS)."1.35Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention. ( Atmani, H; Benkirane-Jessel, N; Clézardin, P; Cortial, D; Daubiné, F; Haïkel, Y; Ladam, G; Voegel, JC, 2009)
"Human breast cancer frequently metastasizes to the skeleton to cause osteolysis and subsequent pain, pathological fracture, and hypercalcemia."1.29Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. ( Boyce, BF; Boyce, R; Chapman, M; Mundy, GR; Sasaki, A; Story, B; Wright, KR; Yoneda, T, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daubiné, F1
Cortial, D1
Ladam, G1
Atmani, H1
Haïkel, Y1
Voegel, JC1
Clézardin, P1
Benkirane-Jessel, N1
Sasaki, A1
Boyce, BF1
Story, B1
Wright, KR1
Chapman, M1
Boyce, R1
Mundy, GR1
Yoneda, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of Neoadjuvant Chemotherapy With or Without Zometa on Occult Micrometastases and Bone Density in Women With Locally Advanced Breast Cancer[NCT00242203]Phase 2120 participants (Actual)Interventional2002-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for risedronic acid and Neoplasm Metastasis

ArticleYear
Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention.
    Biomaterials, 2009, Volume: 30, Issue:31

    Topics: Animals; Antinematodal Agents; beta-Cyclodextrins; Bone Neoplasms; Drug Delivery Systems; Etidronic

2009
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Cancer research, 1995, Aug-15, Volume: 55, Issue:16

    Topics: Animals; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cachexia; Diphosphonates; Etidronic Acid

1995